TransCode Therapeutics, Inc. (NASDAQ:RNAZ) People

TransCode Therapeutics, Inc.

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
Jack E Stover
Other companies: Profusa, Inc. (Chief Executive Officer · Since at least Dec 20, 2021); Traws Pharma, Inc. (Director · Since at least May 18, 2016); PharmaCyte Biotech, Inc. (Director · Aug 15, 2022 – Aug 15, 2022 · Past); Antares Pharma Inc (President and CEO, Director · Jan 25, 2006 – May 14, 2008 · Past); Interpace Biosciences, Inc. (President and CEO, Director · Aug 3, 2005 – Mar 12, 2020 · Past)
Director · Since at least Dec 19, 2025
Elizabeth Czerepak
Other companies: Delcath Systems, Inc. (DIRECTOR · Since at least Feb 14, 2020); Scilex Holding Company (See Remarks · Nov 10, 2022 – Jan 17, 2023 · Past); Sorrento Therapeutics, Inc. (EVP & Chief Financial Officer · Nov 15, 2021 – May 18, 2022 · Past); Spectrum Pharmaceuticals Inc (Director · Jun 19, 2019 – Jun 18, 2020 · Past)
CFO, Director · Since at least Oct 6, 2025
Jack E. Stover
Other companies: Profusa, Inc. (Director · Since at least Aug 20, 2026)
Director · Since at least Dec 22, 2025
Anna MooreChair of Scientific Advisory Board · Since at least Apr 27, 2026
Erik MantingDirector · Since at least Nov 5, 2026
John TattoryInterim CFO · Since at least Sep 10, 2026
Karrie HilsingerVP of Clinical Operations · Since at least Nov 4, 2026
Magda MarquetDirector · Since at least Dec 22, 2025
Michel JanicotConsulting Head of Translational Science · Since at least Nov 17, 2025
Philippe CalaisCEO · Since at least Oct 28, 2026
Robert Michael DudleyChief Executive Officer, Director · Jul 8, 2021 – Sep 28, 2023 · Past
Tania Montgomery-HammonVP, Business Development · Since at least Oct 13, 2026
Thomas A FitzgeraldChief Financial Officer, Director · Since at least Jul 8, 2021
Zdravka MedarovaCofounder/Chief Scientific Officer · Since at least Feb 1, 2022